{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "862",
                "881"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wrodzon\u0105 wad\u0105 serca"
        },
        {},
        {
            "identifier": "T2",
            "position": [
                "694",
                "704"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Verospiron"
        },
        {
            "identifier": "T3",
            "position": [
                "705",
                "723"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "Sta\u0142a opieka w POZ"
        },
        {
            "identifier": "T4",
            "position": [
                "627",
                "661"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "Kontrola w Poradni Kardiologicznej"
        },
        {
            "identifier": "T5",
            "position": [
                "662",
                "668"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "za rok"
        },
        {
            "identifier": "T6",
            "position": [
                "449",
                "518"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Wrodzona wada serca pod postaci\u0105 ubytku w przegrodzie mi\u0119dzykomorowej"
        },
        {
            "icd": "ICD10:Q20",
            "identifier": "N1",
            "referenced": "T1",
            "subtype": "Reference",
            "type": "N",
            "value": "Wrodzone wady rozwojowe jam i po\u00c5\u0082\u00c4\u0085cze\u00c5\u0084 sercowych"
        },
        {
            "icd": "ICD10:Q21.0",
            "identifier": "N2",
            "referenced": "T6",
            "subtype": "Reference",
            "type": "N",
            "value": "Ubytek przegrody mi\u00c4\u0099dzykomorowej"
        },
        {
            "arg1": "T5",
            "arg2": "T3",
            "identifier": "R1",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T5",
            "arg2": "T2",
            "identifier": "R2",
            "subtype": "Dat",
            "type": "R"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 2 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: ICD10:Q21.0|Rozpoznanie II: |Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Wrodzona wada serca pod postaci\u0105 ubytku w przegrodzie mi\u0119dzykomorowej\n------------------------------------------------\nZalecenia\n------------------------------------------------\nKontrola w Poradni Kardiologicznej za rok (Prof. J. Moll)\nOdstawi\u0107 Verospiron\nSta\u0142a opieka w POZ\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nDziewczynka z wrodzon\u0105 wad\u0105 serca przyj\u0119ta do Kliniki do poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan do\u015b\u0107 dobry\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nPotas: K:5.10[mmol/L]\nS\u00f3d: Na:145.00[mmol/L]\nRKZ Parametry krytyczne\n    pH:7.329\n    pCO2:44.2[mmHg]\n    BE:-2.90[mmol/L]\n    HCO3:22.6[mmol/L]\n    pO2:40.8[mmHg]\n    O2Sat:66.6[%]\n    COMMENT_HL7:\nMorfologia\n    WBC:11.64[10\\\\^3/ul]\n    RBC:5.10[10\\\\^6/ul]\n    HGB:13.4[g/dl]\n    HCT:38.7[%]\n    MCV:75.9[fl]\n    MCH:26.3[pg]\n    MCHC:34.6[g/dl]\n    PLT:354.0[10\\\\^3/ul]\n    RDW-SD:34.7[fl]\n    RDW-CV:12.8[%]\n    PDW:11.7[fl]\n    MPV:10.4[fl]\n    P-LCR:27.7[%]\n    PCT:0.4[%]\n    NEUTR#:3.56[10\\\\^3/ul]\n    NEUTR%:30.6[%]\n    LYMPH#:6.26[10\\\\^3/ul]\n    LYMPH%:53.8[%]\n    MONO#:0.90[10\\\\^3/ul]\n    MONO%:7.70[%]\n    EO#:0.83[10\\\\^3/ul]\n    EO%:7.10[%]\n    BASO#:0.09[10\\\\^3/ul]\n    BASO%:0.80[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nImmununochemia -Immulite: COMMENT_HL7:\nFibrynogen (F): FIB:2.61[g/L]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:29.6[s]\nINR: INR:1.0\nCzas protrombinowy (PT): PT:11.2[s]\nCzas trombinowy (TT): TT:15.4[s]\nWap\u0144 ca\u0142kowity: Ca:2.69[mmol/L]\nMagnez: Mg:0.88[mmol/L]\nBilirubina ca\u0142kowita TBIL: TBIL:0.60[mg/dl]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nWska\u017anik PT: PT%:98[%]\nGlukoza osocze: GLU-os:*[mg/dl]\nFe: Fe:126.00[ug/dl]\nKreatynina: CREA:0.30[mg/dl]\nMocznik: UREA:29.00[mg/dl]\nASPAT: AST:45.00[IU/L]\nALAT: ALT:29.00[IU/L]\nNT- proBNP: NTpBNP:90.70[pg/ml]\nGlukoza w surowicy: GLU-sur:71[mg/dl]\nPosiew - Wymaz z nosa: POSIEW:\nPosiew - Wymaz z odbytu: POSIEW:\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:110.1[ml/min/1,73m2]\nWzrost pacjenta: WzrostPac:80[cm]\neGFR (1-18r\u017c K) stand.wg.Schwartza  wsp. 0.550: eGFR 1-18K:146.7[ml/min/1,73m2]\n------------------------------------------------\nICD10\n------------------------------------------------\nQ21.0\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n88.721\n89.602\n87.440\n88.761\n------------------------------------------------"
}